EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
Exploring success factors in the Nordic region for Norway's shift from small projects to a sustainable global pharmaceutical ecosystem.
The triple helix - a good model to illustrate the important collaboration model between the health service, academia and the private sector. The Health and Life Science ecosystem has been identified as a potential growth engine, but despite large investments in R&D, the uptake of innovation is relatively slowly.
- How does this affect Norway's opportunities and ability to attract investment in the sector, not least in the area of clinical trials?
- What barriers exist in the Norwegian system for the uptake of innovation and new ways of working and caring?
- What is at the top of the wish list from the health service and the life science sector?
Presenters:
- Christer Mjåset, Partner, Technology Consulting, EY Norway
- Thomas Straumits, Client Executive, Business Development, Health Science and Wellness, EY Sweden
- Sveinung Stensland, Parliament member
- Morten Egeberg, Administrativ leder UiO:Livsvitenskap & Leder SPARK Norway
Location
EY top floor Client Lounge, Stortorvet 7,
Oslo, Norway, 0155, NO
Date
Time
your local time